Statins × cardiovascular events

SynthesisPloS one2014

Efficacy of standard and intensive statin treatment for the secondary prevention of cardiovascular and cerebrovascular events in diabetes patients: a meta-analysis.

Folgerdiena M de Vries et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedrandomised · 805 people · 2014

Randomised comparison

Probably reduced cardiovascular events

−15%−21% to −9%

Bigger than 3 in 10 for cardiovascular events

As reported

RR 0.85, 95% CI 0.79–0.91

What moved togetherboth groups pooled, not the treatment’s effect

Correlation, not cause

Went with fewer cardiovascular events

−15%−21% to −9%

Bigger than 3 in 10 for cardiovascular events

As reported

RR 0.85, 95% CI 0.79–0.91

Two numbers in the abstract

the abstract, start to end

or cerebrovascular event (RR 0.85, 95% CI 0.79-0.91).

or cerebrovascular events (RR 0.85, 95% CI 0.79-0.91) (Fig. 2,

← favours treatmentfavours comparator →
could be chance
Cardiovascular events
RR 0.850.79–0.91
Cardiovascular events
RR 0.850.79–0.91
StatinsCardiovascular events

Statins × cardiovascular eventshelps?replicated

unlikelylikely
0.86not counted
← favours treatmentfavours comparator →
more certainless certain
1 / 6

28 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 25372483